(RWM) ProShares Short Russell2000 - Overview
Etf: Inverse, Etf, Small-Cap, Index
Dividends
| Dividend Yield | 3.66% |
| Yield on Cost 5y | 3.44% |
| Yield CAGR 5y | 89.28% |
| Payout Consistency | 29.4% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.3% |
| Relative Tail Risk | -0.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.75 |
| Alpha | -5.59 |
| Character TTM | |
|---|---|
| Beta | -1.040 |
| Beta Downside | -1.005 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.80% |
| CAGR/Max DD | -0.22 |
Description: RWM ProShares Short Russell2000 January 18, 2026
The ProShares Short Russell 2000 (NYSE ARCA:RWM) is a 1× inverse exchange-traded fund that seeks to deliver the opposite of the daily performance of the Russell 2000 Index, which represents roughly the smallest 2,000 stocks in the Russell 3000. It uses a float-adjusted, market-cap-weighted methodology and is classified as a non-diversified, inverse equity ETF.
Key metrics (as of the latest filing) include an expense ratio of 0.25%, assets under management of approximately $420 million, and an average daily trading volume of about 1.2 million shares, indicating solid liquidity for intraday positioning.
The fund’s performance is most sensitive to small-cap equity dynamics, which are driven by macro variables such as U.S. monetary policy, consumer confidence, and the health of the domestic manufacturing sector. A tightening cycle or recessionary outlook tends to depress the Russell 2000, thereby benefitting RWM, while a strong economic rebound can erode its inverse exposure.
Because RWM resets its exposure daily, compounding effects can cause returns to diverge from the simple inverse of the index over longer horizons; investors should therefore treat it as a short-term tactical tool rather than a buy-and-hold vehicle.
For a deeper, data-driven analysis of how RWM’s risk-adjusted returns compare to other inverse small-cap products, you might explore the analytics platform ValueRay.
What is the price of RWM shares?
Over the past week, the price has changed by -1.81%, over one month by -2.32%, over three months by -8.16% and over the past year by -14.32%.
Is RWM a buy, sell or hold?
What are the forecasts/targets for the RWM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 15.7 | 3.3% |
RWM Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 104.0m USD (104.0m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 104.0m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 104.0m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 2.08% (E(104.0m)/V(104.0m) * Re(2.08%) + (debt-free company))
Discount Rate = 2.08% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)